fareston
orion corporation - toremifen - bryst neoplasmer - endokrine terapi - første linjehormonbehandling af hormonafhængig metastatisk brystkræft hos postmenopausale patienter. fareston anbefales ikke til patienter med østrogen-receptor negative tumorer.
luxturna
novartis europharm limited - voretigene neparvovec - leber congenital amaurosis; retinitis pigmentosa - other ophthalmologicals - luxturna er indiceret til behandling af voksne og pædiatriske patienter med tab af synet på grund af arvelig retinal dystrofi skyldes bekræftet biallelic rpe65 mutationer, og som har tilstrækkelig levedygtige celler retinal.
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "reddy" 100 mg/ml injektionsvæske, opløsning
reddy holding gmbh - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "qilu" 100 mg/ml injektionsvæske, opløsning
qilu pharma spain s.l. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
bridion
merck sharp & dohme b.v. - sugammadex - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for peadiatric befolkning: sugammadex er kun anbefales til rutinemæssig tilbageførsel af rocuronium-induceret blokade i børn og unge.